XML 32 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Consolidated Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2012
Quarterly Consolidated Financial Data (Unaudited)  
Schedule of unaudited quarterly consolidated financial data

 

 

 

 

Quarter Ended

 

 

 

March 31,
2012

 

June 30,
2012

 

September 30,
2012

 

December 31,
2012

 

 

 

(dollars in thousands, except share and per share data)

 

Revenues

 

$

 

$

 

$

 

$

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Research and Development

 

5,338

 

7,626

 

7,245

 

9,085

 

Purchased in-process research and development

 

 

 

1,000

 

 

General and administrative

 

1,732

 

1,919

 

1,843

 

2,447

 

Loss from operations

 

(7,070

)

(9,545

)

(10,088

)

(11,532

)

 

 

 

 

 

 

 

 

 

 

Other income

 

 

256

 

 

250

 

Interest and investment income

 

39

 

48

 

63

 

68

 

Change in fair value of derivative instruments—warrants

 

8

 

(1,317

)

140

 

(764

)

Total Other Income/ (Loss)

 

47

 

(1,013

)

203

 

(446

)

Net Loss

 

$

(7,023

)

$

(10,558

)

$

(9,885

)

$

(11,978

)

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding—basic and diluted

 

54,298,079

 

60,416,068

 

65,806,178

 

66,194,306

 

Net loss per Common Share, basic and diluted(a):

 

$

(0.13

)

$

(0.17

)

$

(0.15

)

$

(0.18

)

 

 

(a)   Basic and diluted EPS are computed independently for each of the periods presented. Accordingly, the sum of the quarterly EPS amounts may not agree to the total for the year.

 

 

 

Quarter Ended

 

 

 

March 31,
2011

 

June 30,
2011

 

September 30,
2011

 

December 31,
2011

 

 

 

(dollars in thousands, except per share data)

 

Revenues

 

$

 

$

 

$

 

$

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Research and Development

 

1,478

 

2,355

 

3,883

 

5,703

 

General and administrative

 

1,897

 

1,524

 

1,103

 

2,222

 

Loss from operations

 

(3,375

)

(3,879

)

(4,986

)

(7,925

)

Other income

 

 

 

 

362

 

Interest and investment income

 

24

 

20

 

20

 

26

 

Interest expense

 

(12

)

 

 

 

Change in fair value of derivative instruments—warrants

 

(339

)

(698

)

4,383

 

1,911

 

Total Other Income/(Loss)

 

(327

)

(678

)

4,403

 

2,299

 

Net Loss

 

$

(3,702

)

$

(4,557

)

$

(583

)

$

(5,626

)

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding—basic and diluted (a)

 

46,167,416

 

46,642,901

 

47,308,946

 

48,657,013

 

Net loss per common share—basic and diluted(b):

 

$

(0.08

)

$

(0.10

)

$

(0.01

)

$

(0.12

)

 

 

(a)   Weighted average common shares outstanding represented above reflect a retroactive change of a one for two (1:2) reverse stock split effective on November 30, 2011.

 

(b)   Basic and diluted EPS are computed independently for each of the periods presented. Accordingly, the sum of the quarterly EPS amounts may not agree to the total for the year.